Osimertinib related cardiotoxicity in patients with non-small cell lung cancer

被引：0
|
作者：
Mensah, Samuel Akaakole [1 ]
Alruwaili, Waleed [1 ]
Ahmad, Syed [1 ]
Patel, Brijesh [1 ]
Almubarak, Mohammed [1 ]
机构：
[1] West Virginia Univ, Morgantown, WV 26506 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20011
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Influence of interleukin-6 on the pharmacokinetics and pharmacodynamics of osimertinib in patients with non-small cell lung cancer
    Yokota, Hayato
    Sato, Kazuhiro
    Sakamoto, Sho
    Okuda, Yuji
    Takeda, Masahide
    Akamine, Yumiko
    Nakayama, Katsutoshi
    Miura, Masatomo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2025, 95 (01)
  • [42] Osimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer
    van Veggel, B.
    van der Wekken, A.
    Hashemi, S.
    Cornelissen, R.
    Monkhorst, K.
    Heideman, D.
    Radonic, T.
    Smit, E. F.
    Schuuring, E.
    De Langen, J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [43] Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance
    Kai Fu
    Fachao Xie
    Fang Wang
    Liwu Fu
    Journal of Hematology & Oncology, 15
  • [44] Simulation CT Features and Radiation Cardiotoxicity in Non-Small Cell Lung Cancer
    Walls, G.
    Johnston, D.
    Harbsinson, M.
    McCann, C.
    McKavanagh, P.
    Giacometti, V.
    McAleese, J.
    Cole, A.
    Butterworth, K.
    McGarry, C.
    Jain, S.
    Hanna, G. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E69 - E69
  • [45] Osimertinib for non-small-cell Lung Cancer
    Alakus, Hakan
    Zander, Thomas
    Bruns, Christiane
    ONKOLOGE, 2018, 24 (02): : 174 - 176
  • [46] An innovative AXL blocker eliminates osimertinib resistance in non-small cell lung cancer
    Rhie, Byung-Ho
    Choi, Myeong Jun
    Park, Young Jun
    Kim, Sammy L.
    Hong, Yoonki
    Ramakrishna, Suresh
    CANCER SCIENCE, 2025, 116 : 337 - 337
  • [47] Targeting HER2 Aberrations in Non-Small Cell Lung Cancer with Osimertinib
    Liu, Shengwu
    Li, Shuai
    Hai, Josephine
    Wang, Xiaoen
    Chen, Ting
    Quinn, Max M.
    Gao, Peng
    Zhang, Yanxi
    Ji, Hongbin
    Cross, Darren A. E.
    Wong, Kwok-Kin
    CLINICAL CANCER RESEARCH, 2018, 24 (11) : 2594 - 2604
  • [48] Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
    Alessandro Leonetti
    Sugandhi Sharma
    Roberta Minari
    Paola Perego
    Elisa Giovannetti
    Marcello Tiseo
    British Journal of Cancer, 2019, 121 : 725 - 737
  • [49] Tackling Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer
    Blaquier, Juan Bautista
    Ortiz-Cuaran, Sandra
    Ricciuti, Biagio
    Mezquita, Laura
    Cardona, Andres Felipe
    Recondo, Gonzalo
    CLINICAL CANCER RESEARCH, 2023, 29 (18) : 3579 - 3591
  • [50] Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
    Leonetti, Alessandro
    Sharma, Sugandhi
    Minari, Roberta
    Perego, Paola
    Giovannetti, Elisa
    Tiseo, Marcello
    BRITISH JOURNAL OF CANCER, 2019, 121 (09) : 725 - 737
12345